GLEEVEC (imatinib mesylate) ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ·+11 Novartis Pharmaceuticals
ILARIS (canakinumab/PF) ANTI-INFLAMMATORY - INTERLEUKIN 1 RECEPTOR ANTAGONIST · ACUTE GOUTY ARTHRITIS ·+7 Novartis Pharmaceuticals
JADENU (deferasirox) IRON CHELATING AGENTS · CHRONIC IRON OVERLOAD DUE TO REPEATED BLOOD TRANSFUSIONS ·+1 Novartis Pharmaceuticals
JADENU SPRINKLE (deferasirox) IRON CHELATING AGENTS · CHRONIC IRON OVERLOAD DUE TO REPEATED BLOOD TRANSFUSIONS ·+1 Novartis Pharmaceuticals
KISQALI (ribociclib succinate) ANTINEOPLASTIC- CYCLIN-DEPENDENT KINASE (CDK) 4/6 INHIBITORS · HORMONE RECEPTOR (HR)-POSITIVE, HER2-NEGATIVE ADVANCED BREAST CANCER ·+1 Novartis Pharmaceuticals
KYMRIAH (tisagenlecleucel) ANTINEOPLASTIC - CAR-T/TCR-T CELL IMMUNOTHERAPY · B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA Novartis Pharmaceuticals
LEQVIO (inclisiran sodium) ANTIHYPERLIPIDEMIC - PCSK9 INHIBITORS · HYPERCHOLESTEROLEMIA ·+2 Novartis Pharmaceuticals
MAYZENT (siponimod) MULTIPLE SCLEROSIS AGENTS, GENERAL · RELAPSING FORM OF MULTIPLE SCLEROSIS Novartis Pharmaceuticals
MEKINIST (trametinib dimethyl sulfoxide) ANTINEOPLASTIC - MEK1 AND MEK2 KINASE INHIBITORS · MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+5 Novartis Pharmaceuticals
MYFORTIC (mycophenolate sodium) IMMUNOSUPPRESSIVE INOSINE MONOPHOSPHATE DEHYDROGENASE INHIB. · PREVENTION OF KIDNEY TRANSPLANT REJECTION Novartis Pharmaceuticals
NEORAL (cyclosporine, modified) ANTIPSORIATICS · SEVERE RECALCITRANT PSORIASIS ·+4 Novartis Pharmaceuticals
PIQRAY (alpelisib) ANTINEOPLASTIC - PHOSPHATIDYLINOSITOL 3-KINASE ALPHA INHIB. · HORMONE RECEPTOR (HR)-POSITIVE, HER2-NEGATIVE, PIK3CA MUTATED ADVANCED BREAST CANCER Novartis Pharmaceuticals
PLUVICTO (lutetium Lu-177 vipivotide tetraxetan) METASTATIC PROSTATE CARCINOMA ·+1 Novartis Pharmaceuticals
PROMACTA (eltrombopag olamine) THROMBOPOIETIC GROWTH FACTORS · APLASTIC ANEMIA ·+2 Novartis Pharmaceuticals
RHAPSIDO (remibrutinib) SPLEEN/BRUTON'S TYROSINE KINASE INHIBITORS · CHRONIC IDIOPATHIC URTICARIA ·+1 Novartis Pharmaceuticals
RYDAPT (midostaurin) ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ACUTE MYELOID LEUKEMIA WITH FMS-LIKE TYROSINE KINASE-3 (FLT3) MUTATION ·+3 Novartis Pharmaceuticals
SANDIMMUNE (cyclosporine) ANTIPSORIATICS · PREVENTION OF KIDNEY TRANSPLANT REJECTION ·+2 Novartis Pharmaceuticals
SANDOSTATIN LAR DEPOT (octreotide acetate, microspheres) SOMATOSTATIC AGENTS · ACROMEGALY ·+2 Novartis Pharmaceuticals
SCEMBLIX (asciminib hydrochloride) ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · CHRONIC PHASE PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOCYTIC LEUKEMIA ·+1 Novartis Pharmaceuticals
SIMULECT (basiliximab) MONOCLONAL ANTIBODY IMMUNOSUPPRESSIVES · PREVENTION OF KIDNEY TRANSPLANT REJECTION Novartis Pharmaceuticals
TABRECTA (capmatinib hydrochloride) ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · NON-SMALL CELL LUNG CANCER WITH MESENCHYMAL-EPITHELIAL TRANSITION (MET) EXON 14 SKIPPING Novartis Pharmaceuticals
TAFINLAR (dabrafenib mesylate) ANTINEOPLASTIC - BRAF KINASE INHIBITORS · MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+5 Novartis Pharmaceuticals
TASIGNA (nilotinib HCl) ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · CHRONIC PHASE PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOCYTIC LEUKEMIA ·+1 Novartis Pharmaceuticals
